RELATIONSHIP BETWEEN ANXIETY, DEPRESSION, STRESS AND T3, FT4, TSH, TRAb IN GRAVES PATIENTS AT NATIONAL HOSPITAL OF ENDOCRINOLOGY

Ngọc Đinh Thị, Thanh Nguyễn Hoàng, Quân Đỗ Trung, Dương Vũ Qúy

Main Article Content

Abstract

Objective: To determine the relationship between T3, FT4, TSH, TRAb and levels of anxiety, depression, stress in Basedow patients. Methodology: Cross-sectional descriptive study with analysis on 351 patients diagnosed with Basedow. Biochemical indices T3, FT4, TSH, TRAb were quantified. Anxiety, depression, and stress levels were assessed using the DASS-21 scale. Multivariable logistic regression analysis was used to identify independent factors associated with psychological disorders. Logistic regression models were applied to three different sample groups: n=351 (only FT4 and TSH available); n=244 (missing T3) and n=164 (complete data on T3, FT4, TSH, TRAb). Results: In the N=164 group, TRAb was significantly associated with the risk of stress (p=0.015, OR=1.041) and depression (p=0.014, OR=1.041). FT4, TSH, and T3 were not significantly associated with anxiety or stress. In the N=244 group, TRAb continued to show a trend of association with anxiety and depression, though statistical significance was not reached. In the N=351 group, FT4 showed a significant association with the risk of anxiety and stress, suggesting that FT4 may be a weak predictor, detectable only with a larger sample size. Conclusion: TRAb appears to be the most consistently associated factor with the risk of stress and depression across regression models. FT4 may have predictive value for anxiety and stress, but larger studies are needed to confirm its role. Thyroid hormone indices could serve as potential markers for psychological risk screening in Basedow patients and should be considered in comprehensive clinical assessments.


 

Article Details

References

1. Lê Huy Liệu. Bệnh Basedow. In: Bách Khoa Thư Bệnh Học. Vol I. Trung tâm quốc gia biên soạn từ điển bách khoa Việt Nam; 1991:28-30.
2. Jameson JL, Mandel SJ, Weetman AP. Disorders of the Thyroid Gland. In: Jameson JL, ed. Harrison’s Endocrinology, 4e. McGraw-Hill Education; 2017. Accessed July 3, 2024. accessbiomedicalscience.mhmedical.com/content.aspx?aid=1141274506
3. Bộ Y tế (last). Bệnh tuyến giáp. In: Hướng Dẫn Chẩn Đoán và Điều Trị Bệnh Nội Tiết- Chuyển Hóa. ; 2015:51-70.
4. Chen HH, Yeh SY, Lin CL, Chang SN, Kao CH. Increased depression, diabetes and diabetic complications in Graves’ disease patients in Asia. QJM: An International Journal of Medicine. 2014;107(9):727-733. doi:10.1093/qjmed/hcu069
5. Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid®. 2016;26(10):1343-1421. doi:10.1089/thy.2016.0229
6. Fukao A, Takamatsu J, Arishima T, et al. Graves’ disease and mental disorders. Journal of Clinical & Translational Endocrinology. 2020;19: 100207. doi:10.1016/j.jcte.2019.100207
7. Nguyễn Thị Hoài Thu, Nguyễn Lân Việt. Bệnh Lý Tuyến Giáp. Nhà xuất bản Y học; 2012.
8. Trần Ngọc Lương, Phạm Thị Thu Hà. Đặc điểm lâm sàng và cận lâm sàng của bệnh nhân Basedow tại bệnh viện Nội Tiết Trung Ương. tạp chí y học Việt Nam. 2018;470:112-117.
9. Smith TJ, Hegedüs L. Graves’ Disease. Longo DL, ed. N Engl J Med. 2016;375(16):1552-1565. doi:10.1056/NEJMra1510030
10. Campbell M, Jahanshad N, Mufford M, et al. Overlap in genetic risk for cross-disorder vulnerability to mental disorders and genetic risk for altered subcortical brain volumes. Journal of Affective Disorders. 2021;282:740-756. doi:10. 1016/j.jad.2020.12.062